1 |
Huttner HB, Schwab S. Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives [J]. Lancet Neurol, 2009, 8(10): 949-958.
|
2 |
Miao JF, Song XY, Sun WZ, et al. Predictors of malignant cerebral edema in cerebral artery infarction: A meta-analysis [J]. J Neurol Sci, 2020, 409: 116607.
|
3 |
Fuhrer H, Schonenberger S, Niesen WD, et al. Endovascular stroke treatment's impact on malignant type of edema (ESTIMATE) [J]. J Neurol, 2019, 266(1): 223-231.
|
4 |
Hansen HC, Helmke K. The subarachnoid space surrounding the optic nerves: An ultrasound study of the optic nerve sheath [J]. Surg Radiol Anat, 1996, 18(4): 323-328.
|
5 |
Lochner P, Fassbender K, Andrejewski A, et al. Sonography of optic nerve sheath diameter identifies patients with middle cerebral artery infarction at risk of a malignant course: a pilot prospective observational study [J]. J Neurol, 2020, 267(9): 2713-2720.
|
6 |
Vaiman M, Gottlieb P, Bekerman I. Quantitative relations between the eyeball, the optic nerve, and the optic canal important for intracranial pressure monitoring [J]. Head Face Med, 2014, 10: 32.
|
7 |
Albert AF, Kirkman MA. Clinical and radiological predictors of malignant middle cerebral artery infarction development and outcomes [J]. J Stroke Cerebrovasc Dis, 2017, 26(11): 2671-2679.
|
8 |
Legros V, Lefour S, Bard M, et al. Optic nerve and perioptic sheath diameter (ONSD), eyeball transverse diameter (ETD) and ONSD/ETD ratio on MRI in large middle cerebral artery infarcts: a case-control study [J]. J Stroke Cerebrovasc Dis, 2021, 30(3): 105500.
|
9 |
Lee SJ, Choi MH, Lee SE, et al. Optic nerve sheath diameter change in prediction of malignant cerebral edema in ischemic stroke: an observational study [J]. BMC Neurol, 2020, 20(1): 354.
|
10 |
Broocks G, Flottmann F, Ernst M, et al. Computed tomography-based imaging of Voxel-Wise lesion water uptake in ischemic brain relationship between density and direct volumetry [J]. Invest Radiol, 2018, 53(4): 207-213.
|
11 |
Broocks G, Flottmann F, Scheibel A, et al. Quantitative lesion water uptake in acute stroke computed tomography is a predictor of malignant infarction [J]. Stroke, 2018, 49(8): 1906-1912.
|
12 |
Xu HB, Sun YF, Luo N, et al. Net water uptake calculated in standardized and blindly outlined regions of the middle cerebral artery territory predicts the development of malignant edema in patients with acute large hemispheric infarction [J]. Front Neurol, 2021, 12: 645590.
|
13 |
Fu BW, Qi SL, Tao L, et al. Image patch-based net water uptake and radiomics models predict malignant cerebral edema after ischemic stroke [J]. Front Neurol, 2020, 11: 609747.
|
14 |
Schirmer MD, Etherton DM, Dalca DA, et al. Effective reserve: a latent variable to improve outcome prediction in stroke [J]. J Stroke Cerebrovasc Dis, 2019, 28(1): 63-69.
|
15 |
Lee SH, Oh CW, Han JH, et al. The effect of brain atrophy on outcome after a large cerebral infarction [J]. J Neurol Neurosurg Psychiatry, 2010, 81(12): 1316-1321.
|
16 |
Thomalla GJ, Kucinski T, Schoder V, et al. Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging [J]. Stroke, 2003, 34(8): 1892-1899.
|
17 |
Beck C, Kruetzelmann A, Forkert ND, et al. A simple brain atrophy measure improves the prediction of malignant middle cerebral artery infarction by acute DWI lesion volume [J]. J Neurol, 2014, 261(6): 1097-1103.
|
18 |
Goto Y, Kumura E, Watabe T, et al. Prediction of malignant middle cerebral artery infarction in elderly patients [J]. J Stroke Cerebrovasc Dis, 2016, 25(6): 1389-1395.
|
19 |
Kauw F, Bennink E, de Jong H, et al. Intracranial cerebrospinal fluid volume as a predictor of malignant middle cerebral artery infarction [J]. Stroke, 2019, 50(6): 1437-1443.
|
20 |
Minnerup J, Wersching H, Ringelstein EB, et al. Prediction of malignant middle cerebral artery infarction using computed tomography-based intracranial volume reserve measurements [J]. Stroke, 2011, 42(12): 3403-3409.
|
21 |
Dhar R, Chen Y, Hamzehloo A, et al. Reduction in cerebrospinal fluid volume as an early quantitative biomarker of cerebral edema after ischemic stroke [J]. Stroke, 2020, 51(2): 462-467.
|
22 |
Ong CJ, Gluckstein J, Laurido-Soto O, et al. Enhanced detection of edema in malignant anterior circulation stroke (EDEMA) score: a risk prediction tool [J]. Stroke, 2017, 48(7): 1969-1972.
|
23 |
Cheng Y, Wu S, Wang Y, et al. External validation and modification of the EDEMA score for predicting malignant brain edema after acute ischemic stroke [J]. Neurocrit Care, 2020, 32(1): 104-112.
|
24 |
Bechstein M, Meyer L, Breuel S, et al. Computed tomography based score of early ischemic changes predicts malignant infarction [J]. Front Neurol, 2021, 12: 669828.
|
25 |
Muscari A, Faccioli L, Lega MV, et al. Predicting cerebral edema in ischemic stroke patients [J]. Neurol Sci, 2019, 40(4): 745-752.
|
26 |
Chen R, Deng Z, Song Z. The prediction of malignant middle cerebral artery infarction: a predicting approach using random forest [J]. J Stroke Cerebrovasc Dis, 2015, 24(5): 958-964.
|
27 |
Fu BW, Qi SL, Tao L, et al. Image patch-based net water uptake and radiomics models predict malignant cerebral edema after ischemic stroke [J]. Front Neurol, 2020, 11: 609747.
|
28 |
Foroushani HM, Hamzehloo A, Kumar A, et al. Quantitative serial CT imaging-derived features improve prediction of malignant cerebral edema after ischemic stroke [J]. Neurocrit Care, 2020, 33(3): 785-792.
|
29 |
Wang C, Gao L, Zhang ZG, et al. Procalcitonin is a stronger predictor of long-term functional outcome and mortality than high-sensitivity c-reactive protein in patients with ischemic stroke [J]. Mol Neurobiol, 2016, 53(3): 1509-1517.
|
30 |
Zhang Y, Liu G, Wang Y, et al. Procalcitonin as a biomarker for malignant cerebral edema in massive cerebral infarction [J]. Sci Rep, 2018, 8(1): 993.
|
31 |
Marumo T, Eto K, Wake H, et al. The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice [J]. Br J Pharmacol, 2010, 161(6): 1391-1402.
|
32 |
Yi X, Zhou Q, Qing T, et al. 20-hydroxyeiscosatetraenoic acid may be as a predictor of malignant middle cerebral artery infarction in patients with massive middle cerebral artery infarction [J]. BMC Neurol, 2021, 21(1): 437.
|
33 |
Zhao YH, Gao H, Pan ZY, et al. Prognostic value of NT-proBNP after ischemic stroke: a systematic review and meta-analysis of prospective cohort studies [J]. J Stroke Cerebrovasc Dis, 2020, 29(4): 104659.
|
34 |
Zhang X, Yan S, Zhong W, et al. Early NT-ProBNP (N-terminal probrain natriuretic peptide) elevation predicts malignant edema and death after reperfusion therapy in acute ischemic stroke patients [J]. Stroke, 2021, 52(2): 537-542.
|
35 |
Bai XL, Wang CY, Wang L, et al. Association between neutrophil to lymphocyte ratio and malignant brain edema in patients with large hemispheric infarction [J]. Curr Neurovasc Res, 2020, 17(4): 429-436.
|
36 |
Gao L, Dong Q, Song Z, et al. NLRP3 inflammasome: a promising target in ischemic stroke [J]. Inflamm Res, 2017, 66(1): 17-24.
|
37 |
Wang HN, Chen HP, Jin J, et al. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion [J]. Life Sci, 2020, 251: 117638.
|
38 |
Wang Y, Huang H, He W, et al. Association between serum NLRP3 and malignant brain edema in patients with acute ischemic stroke [J]. BMC Neurol, 2021, 21(1): 341.
|